Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
about
Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results.Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts.Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.Improving external beam radiotherapy by combination with internal irradiationHER family inhibitors in pancreatic cancer: current status and future directions.Receptor signaling as a regulatory mechanism of DNA repair.Cancer stem cells and radiotherapy.Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.Isobologram analysis of triple therapies.Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancerPotential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay.The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models.[Experimental tumor therapy].
P2860
Q33353609-C73728D6-0398-43C0-A6C1-46C0DD8A81B8Q34291564-D5426F34-0D3E-4C1F-9303-C2D02AAFDF3FQ34740289-B445ADD9-B060-4570-9EF5-13A5435E7295Q35966191-379BDA09-E915-4D71-B0F5-EBB01342B378Q36219713-642EDE3F-5945-49DA-BF1C-A052F9905628Q36235732-B9A6BD0F-A116-4F80-811A-01F5BDF964C1Q36734936-71C66444-D3C6-4F4A-8335-9203443090AFQ37368256-DACBFE4A-B86B-447D-983B-B8B9E042DEA1Q37453248-8F638E49-9BDF-4085-852D-18936487A221Q37628728-50CFA262-D808-4E55-8D16-C17C3AC43442Q37676970-EAD06520-B301-4437-ADE6-9894918E35B3Q39065896-41F2B418-7A35-4BEA-9992-61F7ABFDA33DQ39289085-23988C40-B385-4883-9BF5-AFB3893486FAQ39939644-E4645A40-C95F-4B2F-8350-88D9310FC33DQ51749302-29782CE2-DD28-4246-95D3-25D1A5D67EEFQ52627703-1DCA4B9A-8FDA-49CA-A947-FABE09037F93Q54490610-C3912640-E2EE-4EFA-944A-9CE70E70B2B2
P2860
Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@en
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@nl
type
label
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@en
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@nl
prefLabel
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@en
Different classes of EGFR inhi ...... a study on C225 in FaDu hSCC.
@nl
P2093
P1476
Different classes of EGFR inhi ...... : a study on C225 in FaDu hSCC
@en
P2093
P304
P356
10.1016/J.RADONC.2004.10.011
P577
2004-11-25T00:00:00Z